{"id":"W2889097815","doi":"10.1016/j.clml.2018.07.155","title":"Extended 5-Year Follow-Up of the Phase 3 ELOQUENT-2 Study of Elotuzumab Plus Lenalidomide/Dexamethasone (ELd) Versus Ld in Relapsed/Refractory Multiple Myeloma (RRMM)","year":2018,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; Dalhousie University","funders":"","keywords":"Lenalidomide; Dexamethasone; Multiple myeloma; Medicine; Oncology; Internal medicine; Milestone; Progression-free survival; Cancer research; Overall survival","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006949243,0.001311552,0.003644849,0.0006609625,0.001106178,0.00194904,0.001097542,0.002018166,0.00367476],"category_scores_gemma":[0.003422883,0.0005292257,0.00371795,0.000748203,0.0008862139,0.002621602,0.0009254867,0.003738775,0.0008630641],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001275391,"about_ca_system_score_gemma":0.001361117,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002064375,"about_ca_topic_score_gemma":0.004248142,"domain_scores_codex":[0.9979678,0.0008292285,0.0001187643,0.0003394709,0.0001996381,0.0005451257],"domain_scores_gemma":[0.9968811,0.0006717278,0.0006763712,0.0004323026,0.0002732422,0.001065272],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8744827,0.009028407,0.02998352,0.0004263748,0.006716938,0.0002687712,0.0003196321,0.001657658,0.005419808,0.0001954985,0.003116663,0.06838406],"study_design_scores_gemma":[0.2635701,0.3644805,0.3413111,0.0002770063,0.01228075,0.0005948482,0.000364409,0.001942257,0.003343781,0.001080676,0.01059823,0.0001563359],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.983569,0.00782991,0.0006833672,0.0006713282,0.0002827659,0.0005304868,0.004018772,0.00009101123,0.00232349],"genre_scores_gemma":[0.9871927,0.001252222,0.0005775209,0.001334511,0.0002498034,0.0004086854,0.006726319,0.00002871229,0.002229447],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006949243,"threshold_uncertainty_score":0.03675157,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07937008621541364,"score_gpt":0.3886256237391009,"score_spread":0.3092555375236873,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}